211 related articles for article (PubMed ID: 34712723)
21. Over-expression of mammaglobin-B in canine mammary tumors.
Pandey M; Sunil Kumar BV; Gupta K; Sethi RS; Kumar A; Verma R
BMC Vet Res; 2018 Jun; 14(1):184. PubMed ID: 29903015
[TBL] [Abstract][Full Text] [Related]
22. Benzyl Isothiocyanate Induces Apoptosis and Inhibits Tumor Growth in Canine Mammary Carcinoma via Downregulation of the Cyclin B1/Cdk1 Pathway.
Cheng N; Diao H; Lin Z; Gao J; Zhao Y; Zhang W; Wang Q; Lin J; Zhang D; Jin Y; Bao Y; Lin D
Front Vet Sci; 2020; 7():580530. PubMed ID: 33263014
[No Abstract] [Full Text] [Related]
23. Anticancer effects of alpelisib on PIK3CA-mutated canine mammary tumor cell lines.
Yeom J; Cho Y; Ahn S; Jeung S
Front Vet Sci; 2023; 10():1279535. PubMed ID: 38033642
[TBL] [Abstract][Full Text] [Related]
24. Expression of secreted frizzled-related protein 2 in a primary canine mammary tumor cell line: a candidate tumor marker for mammary tumor cells.
Lee JL; Chang CJ; Chueh LL; Lin CT
In Vitro Cell Dev Biol Anim; 2003; 39(5-6):221-7. PubMed ID: 12866949
[TBL] [Abstract][Full Text] [Related]
25. Thyroglobulin as a negative marker for malignancy in canine and human breast tumors.
Hwang SH; Yang Y; Woo SH; Jung JH; Seo D; Kim DY; Kim Y
Mol Carcinog; 2021 Jul; 60(7):455-468. PubMed ID: 34003526
[TBL] [Abstract][Full Text] [Related]
26. Assessment of the tumorigenesis and drug susceptibility of three new canine mammary tumor cell lines.
Chang CY; Chiou PP; Chen WJ; Li YH; Yiu JC; Cheng YH; Chen SD; Lin CT; Lai YS
Res Vet Sci; 2010 Apr; 88(2):285-93. PubMed ID: 19748110
[TBL] [Abstract][Full Text] [Related]
27. Progesterone receptor membrane component 1 (PGRMC1) expression in canine mammary tumors: A preliminary study.
Terzaghi L; Banco B; Groppetti D; Dall'Acqua PC; Giudice C; Pecile A; Grieco V; Lodde V; Luciano AM
Res Vet Sci; 2020 Oct; 132():101-107. PubMed ID: 32544632
[TBL] [Abstract][Full Text] [Related]
28. Significance of caveolin-1 and matrix metalloproteinase 14 gene expression in canine mammary tumours.
Ebisawa M; Iwano H; Nishikawa M; Tochigi Y; Komatsu T; Endou Y; Hirayama K; Taniyama H; Kadosawa T; Yokota H
Vet J; 2015 Nov; 206(2):191-6. PubMed ID: 26364240
[TBL] [Abstract][Full Text] [Related]
29. Properties of cellular and serum forms of thymidine kinase 1 (TK1) in dogs with acute lymphocytic leukemia (ALL) and canine mammary tumors (CMTs): implications for TK1 as a proliferation biomarker.
Jagarlamudi KK; Westberg S; Rönnberg H; Eriksson S
BMC Vet Res; 2014 Oct; 10():228. PubMed ID: 25293656
[TBL] [Abstract][Full Text] [Related]
30. CA 15-3 cell lines and tissue expression in canine mammary cancer and the correlation between serum levels and tumour histological grade.
Manuali E; De Giuseppe A; Feliziani F; Forti K; Casciari C; Marchesi MC; Pacifico E; Pawłowski KM; Majchrzak K; Król M
BMC Vet Res; 2012 Jun; 8():86. PubMed ID: 22726603
[TBL] [Abstract][Full Text] [Related]
31. Expression and the molecular forms of neutrophil gelatinase-associated lipocalin and matrix metalloproteinase 9 in canine mammary tumours.
Chen YC; Chang SC; Huang YH; Lee YJ; Chang CC; Liao JW; Hsu WL
Vet Comp Oncol; 2019 Sep; 17(3):427-438. PubMed ID: 31050171
[TBL] [Abstract][Full Text] [Related]
32. The antiprogestins mifepristone and onapristone reduce cell proliferation in the canine mammary carcinoma cell line CMT-U27.
Guil-Luna S; Hellmén E; Sánchez-Céspedes R; Millán Y; Martín de las Mulas J
Histol Histopathol; 2014 Jul; 29(7):949-55. PubMed ID: 24500783
[TBL] [Abstract][Full Text] [Related]
33.
Schabort JJ; Nam AR; Lee KH; Kim SW; Lee JE; Cho JY
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218035
[TBL] [Abstract][Full Text] [Related]
34. Validation of a low-cost modified technique for constructing tissue microarrays for canine mammary tumor analysis.
Silva FB; Leite Jda S; de Mello MF; Ferreira AM
Pathol Res Pract; 2016 Sep; 212(9):783-90. PubMed ID: 27461825
[TBL] [Abstract][Full Text] [Related]
35. Significance of ERα, HER2, and CAV1 expression and molecular subtype classification to canine mammary gland tumor.
Shinoda H; Legare ME; Mason GL; Berkbigler JL; Afzali MF; Flint AF; Hanneman WH
J Vet Diagn Invest; 2014 May; 26(3):390-403. PubMed ID: 24760135
[TBL] [Abstract][Full Text] [Related]
36. Expression of VCAN and its receptors in canine mammary carcinomas with or without myoepithelial proliferation.
Figuerêdo SH; Neto RSC; Ferreira E; Cassali GD; Estrela-Lima A; Damasceno KA
Res Vet Sci; 2021 Nov; 140():56-63. PubMed ID: 34399281
[TBL] [Abstract][Full Text] [Related]
37. Effect of the VP3 gene of chicken anemia virus on canine mammary tumor cells.
Lee JJ; Chen PB; Yang SH; Cheng CH; Chueh LL; Pang VF; Hsiao M; Lin CT
Am J Vet Res; 2007 Apr; 68(4):411-22. PubMed ID: 17397298
[TBL] [Abstract][Full Text] [Related]
38. Establishment and Characterization of a New Intrahepatic Cholangiocarcinoma Cell Line, ICC-X2.
Xu H; Chai CP; Tang H; Su YH; Yu C; Li L; Yi JF; Ye ZZ; Wang ZF; Hu JJ; Luo W; Zhang H; Miao X; Zhou WC
World J Oncol; 2024 Feb; 15(1):114-125. PubMed ID: 38274721
[TBL] [Abstract][Full Text] [Related]
39. In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors.
Guillemette S; Rico C; Godin P; Boerboom D; Paquet M
J Mammary Gland Biol Neoplasia; 2017 Sep; 22(3):203-214. PubMed ID: 28822004
[TBL] [Abstract][Full Text] [Related]
40. Canine mammary tumors contain cancer stem-like cells and form spheroids with an embryonic stem cell signature.
Ferletta M; Grawé J; Hellmén E
Int J Dev Biol; 2011; 55(7-9):791-9. PubMed ID: 22161835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]